Cell wall active antifungal agents

Bibliography

• GALLIS HA, DREW RH, PICKARD WW: Amphotericin B: 30 years of clinical experience. Rev Infect. Dis. (1990) 12:308–329.
   PubMedGoogle Scholar
• HIEMENZ JW, WALSH TJ: Lipid formulations of amphotericin B. j Liposome Res. (1998) 8:443–467.
   Web of Science ®Google Scholar
• RODRIGUEZ LJ, REX JH, ANAISSIE EJ: Update on invasive candidiasis. Adv. Pharmacol. (1996) 137:349–400.
   Google Scholar
• SHEEHAN, DJ, HITCHCOCK CA, SIBLEY CM: Current and emerging azole antifungal agents. Gun. Microbial Rev (1999) 12:40–79.
   PubMed Web of Science ®Google Scholar
• REX JM, RINALDI MG, PFALLER MA:Resistance of Caridida species to fluconazole. Aritimicrob. Agents Chemother. (1995) 19:1–8.
   Google Scholar
• BARTIZAL K, GILL CJ, ABRUZZO G et al.: In vitro preclinical evaluation studies with echinocandin antifungal MK-0991 (L-743,872). Aritimicrob. Agents Chemother. (1997) 41:2326–2332.
   PubMed Web of Science ®Google Scholar
• ABRUZZO G, FLATTERY AM, GILL CJ et al: Evaluation of echinocandin antifungal MK-0991 (L-743,872) efficacy in mouse models of disseminated aspergillosis, candidiasis and cryptococcosis. Aritimicrob. Agents Chemother. (1997) 41:2333–2338.
   PubMed Web of Science ®Google Scholar
• ARATHOON A, GOTUZZO E, NORIEGA L et al: Presented at the 36th Annual Meeting of the Infectious Diseases Society of America, Denver CO. (1998).
   Google Scholar
• SABLE CA, VILLANUEVA A, ARATHONE et al: Presented at the 37th Interscience Conference on Antimicriobial Agents and Chemotherapy, Toronto, Canada. (1997).
   Google Scholar
• SCHWARTZ RE, SESIN DF, JOSHUA H et al.: Pneumocandins from Zaleriori arboricola: I. Discovery and isolation. Antibiotics (1992) 45:1853–1856.
   PubMed Web of Science ®Google Scholar
• GEORGOPAPADAKOU NH: Update on antifungals targeted to the cell wall: focus on 3-1,3-glucan synthase inhibitors. Expert Opiri. Irivestig. Drugs (2001) 10(2):269–280.
   PubMed Web of Science ®Google Scholar
• •This reference provides a complimentary review of cell wall active antifungal agents.
   Google Scholar
• GRUNER J, TRAXLER P: Papulacandin, anew antibiotic, active especially against yeasts. Experieritia (1977) 33:137–137.
   Google Scholar
• BENZ F, KNUSEL 1 NUESCH J etal.: Echinocandin B, em n neuartiges Polipeptid-Antibiotikum aus Aspergillus nidularisvar. echiriatus: Isolierung und Bausteine. Hely. Chim. Acta (1974) 57:2459–2477.
   Google Scholar
• DAEHN U, HAGENMAIER H, HOEHNE H et al.: Metabolic products of microorganisms part 154. Nikkomycin, a new inhibitor of fungal chitin synthesis. Arch. Microbial. (1976) 107:143–160.
   Google Scholar
• ISONO K, NAGATSU J, KOBINATA K et al.: Studies on polyoxins, antifungal antibiotics. Part V Isolation and characterization of polyoxins C, D, E, 1 G, H, and I. Agric. Biol. Chem. (1967) 31:190–199.
   Google Scholar
• MIZUNO K, YAGI A, SATOI Metal.: Studies on aculeacin. I. Isolation and characterization of aculeacin. j Antibiotics (1977) 30:281–289.
   Google Scholar
• MUKHOPADHYAY T, ROY K, BHAT RG et al.: Mulundocandin, a new lipopeptide antibiotic. II. Structure elucidation. Antibiotics (1977) 45:618–623.
   Google Scholar
• SCHMATZ DM, ROMANCHECK MA, PITARELLI LA etal.: Treatment of Prieumocystis carinii pneumonia with 1,3-13-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA (1990) 87:5950–5954.
   Google Scholar
• IWAMOTO T, FUJIE A, SAKAMOTO K et al.: WF11899A, B and C, novel antifungal lipopeptides I. Taxonomy, fermentation, isolation and physio-chemical properties. Antibiotics (1994) 47(10):1084–1091.
   Google Scholar
• IWAMOTO T, FUJIE A, NITTA K et al.: WF11899A, B and C, novel antifungal lipopeptides II. Biological properties. Antibiotics (1994) 47(10):1092–1097.
   PubMedGoogle Scholar
• BALKOVEC JM, BLACK RIVI, HAMMOND ML et al.: Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systematic candidiasis and Prieumocystis carinii pneumonia (PCP). Med. Chem. (1992) 35:194–198.
   Google Scholar
• TOMISHIMA M, OHKI H, YAMADA A et al.: FK463, a novel water-soluble echinocandin lipopeptide: synthesis and antifungal activity. j Antibiotics (1999) 52(7):674–676.
   PubMed Web of Science ®Google Scholar
• ••This is a key reference for FK463, animportant semisynthetic sulfated echinocandin.
   Google Scholar
• IKEDA F, WAKAI Y, MOTSUMOTO S et al.: Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob. Agents Chemother. (2000) 44(3):614–618.
   PubMed Web of Science ®Google Scholar
• •This reference provides results of in vivo evaluations of FK463.
   Google Scholar
• MOTSUMOTO S, WAKAI Y, NAIKAI T et al.: Efficacy of FK463, a (1,3)-3-glucan synthase inhibitor, in disseminated azole-resistant Candida albicaris infection in mice. Antimicrob. Agents Chemother. (2000) 44(6):1728–1730.
   PubMedGoogle Scholar
• •This reference provides results of in vivo evaluations of FK463.
   Google Scholar
• MAESAKI S, HOSSAIN MA, MIYAZAKI Y et al.: Efficacy of FK463, anew lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis. Antimicrob. Agents Chemother. (2000) 44(3):619–621.
   PubMedGoogle Scholar
• •This reference provides results of in vivo evaluations of FK463.
   Google Scholar
• ITO M, NOZU R, KURAMOCHI E et al.: Prophylactic effect of FK463, a novel lipopeptide, against Prieumocystis carinli infection in mice. Antimicrob. Agents Chemother. (2000) 44(9):2259–2262.
   PubMed Web of Science ®Google Scholar
• •This reference provides results of in vivo evaluations of FK463.
   Google Scholar
• FUJIE A, IWAMOTO T, MURAMATSU H et al.: FR901469, a novel antifungal antibiotic from an unidentified fungus no. 11243 I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties. j Antibiotics (2000) 53(9):912–919.
   Google Scholar
• ••This is a key reference for the aerothricinlipopeptidolactone FR901469.
   Google Scholar
• FUJIE A, IWAMOTO T, MURAMATSU H et al.: FR901469, a novel antifungal antibiotic from an unidentified fungus no. 11243 II. In vitro and in vivo activities. J. Antibiotics (2000) 53(9):920–927.
   Google Scholar
• ••This is a key reference for the aerothricinlipopeptidolactone FR901469.
   Google Scholar
• BARRETT D, TANAKA A, FUJIE A et al.: An expedient synthesis of the amide analog of the potent antifungal lipopeptidolactone FR901469. Tetrahedron Lett. (2001) 42:703–705.
   Google Scholar
• TANAKA A, BARRETT D, FUJIE A et al.:Site-specific structural transformation of the novel antifungal cyclic depsipeptide FR901469: synthesis and biological activity of FR203903. _J. Antibiotics (2001) 54(2):193–197.
   PubMedGoogle Scholar
• ONISHI J, MEINZ M, THOMPSON J et al.: Discovery of novel antifungal (1,3) D glucan synthase inhibitors. Antimicrob. Agents Chemother (2000) 44(2):368–377.
   PubMed Web of Science ®Google Scholar
• ••This is the critical paper identifyinginhibition of glucan synthesis as the mode of action of the antifungal sterol glycosides.
   Google Scholar
• KUMEDA Y, ASAO T, IIDA A etal.: Effects of ergokonin A produced by Trichoderma viride on the growth and morphological development of fungi. Aritibact. Aritifurig. Ag., Japan (1994) 22(10:663–670.
   Google Scholar
• GORMAN JA, CHANG LP CLARK J et al.: Ascosteroside, a new antifungal agent from Ascotricha amphitlicha. I. Taxonomy, fermentation and biological activities. Antibiotics (1996) 49(6):547–552.
   Google Scholar
• LEET JE, HUANG S, KLOHR SE, MCBRIEN KD: Ascosteroside, a new antifungal agent from Ascotricha amphitlicha. II. Isolation and structure elucidation. j Antibiotics (1996) 49(6):553–559.
   Google Scholar
• ELKIHEL L, SOUSTRE I, KARST F, LETOURNEUX Y: Amino-and aminomethylcholesterol derivatives with fungicidal activity. FEMS Microbial. Letts (1994) 120:163–168.
   PubMedGoogle Scholar
• BILLS G, DOMBROWSKI A, HENSENS 0 et al.: Hyalodendrosides A and B, antifungal triterpenoid glycosides from a lignicoulous hyphomycete, Hyaloderidron species. j Nat. Prod. (2000) 63:90–94.
   Google Scholar
• PELAEZ F, CABELLO A, PLATAS G et al.: The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormoriema species Biological activity and taxonomy of the producing organisms. Systematic and Applied Microbiology (2000) 23:333–343.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the discovery ofenfumafungin.
   Google Scholar
• SCHWARTZ RE, SMITH SK, ONISHI JC et al.: Isolation and structural determination of enfumafungin, a triterpene glycoside antifungal agent that is a specific inhibitor of glucan synthesis. I Am. Chem. Soc. (2000) 122(20):4882–4886.
   Google Scholar
• ••This paper provides details of the isolationand structural determination of enfumafungin.
   Google Scholar
• HWANG El, YUN BS, KIM YK et al.: Chaetoatrosin A, a novel chitin synthase II inhibitor produced by Chaetomium atrobrunrieum F449. I Aritibiot. (2000) 53(3):248–255.
   PubMedGoogle Scholar
• KIM SUN-UK, HWANG EUI-IL, NAM JI-YOUN et al.: Inhibition of chitin synthase II by catechins from stem bark of Taxus cuspidata. Planta Med. (1999) 65:97–98.
   PubMedGoogle Scholar
• DAVIS AL, CAI Y, LEWIS JR: H-1 and C-13 assignments of some green tea polyphenols. Magri. Resort. Chem. (1996) 34:887–890.
   Web of Science ®Google Scholar
• JEONG TS, HWANG El, LEE HB et al: Chitin synthase II inhibitory activity of ursolic acid, isolated from Cratagegus pirmatifida. Planta Med. (1999) 65:261–263.
   PubMed Web of Science ®Google Scholar
• THOMPSON JR, DOUGLAS CM, LI W et al: A glucan synthase FKS1 homolog in Cryptocaccus neaformans is single copy and encodes an essential function. j. Bacterial (1999) 181(2):444–453.
   PubMed Web of Science ®Google Scholar
• HEDGE VR, SILVER J, PATEL M et al:Novel fungal metabolites as cell wall active antifungals: Fermentation, isolation, physico-chemical properties, structure and biological activity. I Antibiotics (2001) 54(1):74–83.
   PubMedGoogle Scholar